Literature DB >> 23179153

Risk factors of organ failure in patients with bacteremic cholangitis.

Ban Seok Lee1, Jin-Hyeok Hwang, Sang Hyub Lee, Sang Eon Jang, Eun Sun Jang, Hyun Jin Jo, Cheol Min Shin, Young Soo Park, Jin-Wook Kim, Sook-Hyang Jung, Nayoung Kim, Dong Ho Lee, Jun Kyu Lee, Soyeon Ahn.   

Abstract

BACKGROUND: Bacteremic cholangitis carries a high mortality rate of up to 10 % in relation to organ failure (OF), including septic shock. AIM: The purpose of this study was to elucidate predictive factors for OF in bacteremic cholangitis.
METHODS: A retrospective review of all patients diagnosed with acute cholangitis and proven bacteremia from 2003 to 2011 was performed. Comprehensive clinical and laboratory data of 211 patients were analyzed.
RESULTS: There were 42 cases (19.9 %) of OF and 5 deaths (2.4 %). In the multivariate logistic regression analysis, significant predictive factors for OF were successful biliary decompression, presence of extended-spectrum beta-lactamase organism (ESBL), higher total bilirubin, and higher blood urea nitrogen (BUN) level at admission with odds ratios (ORs) of 0.129, 6.793, 1.148, and 1.089, respectively. Subgroup analysis of 165 patients who underwent biliary decompression before an event (with OF: 20, without OF: 145) was performed to elucidate the risk factors for organ failure even after successful biliary drainage. Variables significantly associated with OF included ESBL and BUN (OR = 4.123 and 1.177, respectively). We developed a scoring system with regression coefficient of each significant variable. The organ failure score was calculated using the following equation: (1.4 × ESBL) + (0.2 × BUN). This scoring system for predicting OF was highly sensitive (85.0 %) and specific (83.4 %).
CONCLUSIONS: Biliary decompression, ESBL, total bilirubin, and BUN are prognostic determinants in patients with bacteremic cholangitis. An organ failure scoring system may allow clinicians to identify groups with poor prognosis even after successful biliary decompression.

Entities:  

Mesh:

Year:  2012        PMID: 23179153     DOI: 10.1007/s10620-012-2478-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  42 in total

1.  Accuracy of the Tokyo Guidelines for the diagnosis of acute cholangitis and cholecystitis taking into consideration the clinical practice pattern in Japan.

Authors:  Masamichi Yokoe; Tadahiro Takada; Toshihiko Mayumi; Masahiro Yoshida; Hiroshi Hasegawa; Shinji Norimizu; Katsumi Hayashi; Shuichiro Umemura; Etsuro Orito
Journal:  J Hepatobiliary Pancreat Sci       Date:  2011-03       Impact factor: 7.027

2.  Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy.

Authors:  Ebbing Lautenbach; Joshua P Metlay; Warren B Bilker; Paul H Edelstein; Neil O Fishman
Journal:  Clin Infect Dis       Date:  2005-08-24       Impact factor: 9.079

3.  Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group.

Authors:  C Brun-Buisson; F Doyon; J Carlet
Journal:  Am J Respir Crit Care Med       Date:  1996-09       Impact factor: 21.405

4.  Serum and bile interleukin 6 after percutaneous transhepatic cholangio-drainage.

Authors:  T Akiyama; T Hasegawa; T Sejima; H Sahara; K Seto; H Saito; S Takashima
Journal:  Hepatogastroenterology       Date:  1998 May-Jun

5.  Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.

Authors:  Bin Du; Yun Long; Hongzhong Liu; Dechang Chen; Dawei Liu; Yingchun Xu; Xiuli Xie
Journal:  Intensive Care Med       Date:  2002-10-17       Impact factor: 17.440

6.  Elevated blood urea nitrogen is an independent risk factor of prolonged intensive care unit stay due to acute necrotizing pancreatitis.

Authors:  Maik Faisst; Ulrich F Wellner; Stefan Utzolino; Ulrich T Hopt; Tobias Keck
Journal:  J Crit Care       Date:  2009-05-08       Impact factor: 3.425

Review 7.  Management of cholangitis.

Authors:  Philippus C Bornman; Johan I van Beljon; Jake E J Krige
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

Review 8.  Diagnosis and management of cholecystitis and cholangitis.

Authors:  Ian F Yusoff; Jeffrey S Barkun; Alan N Barkun
Journal:  Gastroenterol Clin North Am       Date:  2003-12       Impact factor: 3.806

9.  Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomes.

Authors:  M Melzer; R Toner; S Lacey; E Bettany; G Rait
Journal:  Postgrad Med J       Date:  2007-12       Impact factor: 2.401

10.  Dio-Sensimedia: a novel culture medium for rapid detection of extended spectrum beta-lactamases.

Authors:  Atahan A Cagatay; Tanil Kocagoz; Haluk Eraksoy
Journal:  BMC Infect Dis       Date:  2003-09-25       Impact factor: 3.090

View more
  4 in total

1.  Factors predicting adverse short-term outcomes in patients with acute cholangitis undergoing ERCP: A single center experience.

Authors:  Udayakumar Navaneethan; Norma G Gutierrez; Ramprasad Jegadeesan; Preethi Gk Venkatesh; Madhusudhan R Sanaka; John J Vargo; Mansour A Parsi
Journal:  World J Gastrointest Endosc       Date:  2014-03-16

2.  In vitro synergistic activities of antimicrobial peptide brevinin-2CE with five kinds of antibiotics against multidrug-resistant clinical isolates.

Authors:  Yuan Zhang; Yukun Liu; Yan Sun; Qingmei Liu; Xiaoyan Wang; Zhi Li; Jie Hao
Journal:  Curr Microbiol       Date:  2014-01-29       Impact factor: 2.188

3.  Risk factors of organ failure in cholangitis with bacteriobilia.

Authors:  Jae Min Lee; Sang Hyub Lee; Kwang Hyun Chung; Jin Myung Park; Ban Seok Lee; Woo Hyun Paik; Joo Kyung Park; Ji Kon Ryu; Yong-Tae Kim
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

4.  Factors Associated with Mortality in Severe Acute Cholangitis in a Moroccan Intensive Care Unit: A Retrospective Analysis of 140 Cases.

Authors:  Soumaya Touzani; Abderrahim El Bouazzaoui; Fatima Bouyarmane; Kaoutar Faraj; Nawfal Houari; Brahim Boukatta; Nabil Kanjaa
Journal:  Gastroenterol Res Pract       Date:  2021-01-27       Impact factor: 2.260

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.